Presentation is loading. Please wait.

Presentation is loading. Please wait.

Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations  Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques.

PublishNicholas Goodwin Modified over 5 years ago

Similar presentations

Presentation on theme: "Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations  Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques."— Presentation transcript:

1 Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations  Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques Cassiman, Mahdi Zamani, Harry Cuppens  Journal of Cystic Fibrosis  Volume 7, Issue 2, Pages (March 2008) DOI: /j.jcf Copyright © Terms and Conditions

2 Fig. 1 Geographical distribution of CFTR mutations in Iran. The number of CFTR genes carrying a specific mutation is given. 1U: unknown mutation. Novel mutations described for the first time in this study are given in bold. Most of the Centre, East and South East of Iran are desert and hardly populated. Journal of Cystic Fibrosis 2008 7, DOI: ( /j.jcf ) Copyright © Terms and Conditions

Download ppt "Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations  Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques."

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages 332-384 (March.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis

The prevalence of “risky behaviour” in adults with cystic fibrosis
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A

Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.

CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
A 10-year large-scale cystic fibrosis carrier screening in the Italian population  Luigi Picci, Marilena Cameran, Oriana Marangon, Diana Marzenta, Stefano.

A 10-year large-scale cystic fibrosis carrier screening in the Italian population  Luigi Picci, Marilena Cameran, Oriana Marangon, Diana Marzenta, Stefano.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 

Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 

Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations  Satu Kinnunen, Sandra Bonache, Teresa Casals,

Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations  Satu Kinnunen, Sandra Bonache, Teresa Casals,
Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,

Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Benchmarks for Cystic Fibrosis carrier screening: A European consensus document  Carlo Castellani, Milan Macek, Jean-Jacques Cassiman, Alistair Duff, John.

Benchmarks for Cystic Fibrosis carrier screening: A European consensus document  Carlo Castellani, Milan Macek, Jean-Jacques Cassiman, Alistair Duff, John.
CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent  Martín M. Pérez, María Cecilia.

CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent  Martín M. Pérez, María Cecilia.

Similar presentations

Ads by Google